Please login to the form below

Germany

This page shows the latest Germany news and features for those working in and with pharma, biotech and healthcare.

Currently, Abivax has received approval for studies in France and Germany, as well as in the UK, Italy and Brazil.

GSK strikes $170m-plus ‘synthetic lethality’ cancer deal with Ideaya

In February it extended its position in another core area – cell therapies – via licensing deal with Germany’s Immatics that included $50m upfront for two initial programmes and up to $550m
Policy and public health COVID-19 by the numbers

These eight countries account for 40% of confirmed cases worldwide: Spain, Italy, UK, Germany, France, Belgium, Netherlands, Switzerland.
Sanofi doses first patient in global Kevzara COVID-19 trial

Germany, France, Canada and Russia.
Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19

Earlier this year, bluebird announced that the gene therapy was available in Germany, its first market – while the preparation of patients for treatment in the country is ongoing, the first commercial ... Germany is currently fighting against its own
Germany's coronavirus infections climb but deaths remain low

Currently, Germany has confirmed over 16, 000 cases of coronavirus infections among its citizens – the virus which causes the respiratory disease COVID-19. ... We are still at a relatively early stage in the outbreak in Germany.

More from news
Approximately 45 fully matching, plus 853 partially matching documents found.

Things are going to be different

But the significantly lower rates in France, Germany and the UK show that this is not universally true and remind us that country-by-country variations will be significant.
GSK forges ahead with its dynamic COPD and asthma portfolio

For instance, in the UK, US, Canada and Spain, the first treatment was an ICS/LABA, such Seretide or Symbicort, while in Germany it was a bronchodilator.
As COVID-19 takes over the world, biopharma fights back

The partners have already initiated trials in the US, as well as in a number of other countries including Italy, Spain, Germany, France, Canada and Russia.
The 2019 CPhI Pharma Index Report

Union exit and they have seemingly predicted that Germany will be the primary beneficiary of this move. ... In fact, according to Farmaindustria, Italy has equalled Germany in both total production of finished goods and production per unit.
Building European biotech firms to rival those of the US

Germany is European biotech’s sleeping giant. “Germany is Europe’s great untapped player in biotech,” said Richard. ... For a number of reasons, such as taxes and red tape, the sector hasn’t really taken off there as much as it could have until

More from intelligence
Approximately 9 fully matching, plus 127 partially matching documents found.

McCann Health London bolsters creative leadership team

Delaney has a consumer agency background, which includes two years leading the creative department at McCann Health Germany.
McCann Health Germany strengthens leadership team

Healthcare communications network McCann Health has made two key appointments to the leadership team of McCann Health Germany. . ... Guido Körfer (pictured above) has been appointed as president of McCann Health Germany.
Richard Paulson joins Ipsen as CEO for North America

During a 10-year career at Amgen, Paulson held a number positions at the company, including general manager of Germany and general manager of central and eastern Europe.
Dave Lemus joins Proteros as an executive board member

He joins the German biotech’s board from Medigene. Proteros, a private biotech based in Germany, has appointed Dave Lemus as an executive board member, chief operating officer and chief financial
MC Services welcomes Dr Claudia Gutjahr-Loeser to its management team

She joins the Duesseldorf, Germany-based firm from MorphoSys, where she headed the corporate communications and investor relations department as senior vice president; a role that saw her took responsibility for

More from appointments
Approximately 2 fully matching, plus 75 partially matching documents found.

Candice Subero to Lead Global Marketing for OPEN Health

Together, we have over 700 people in 15 offices across 6 different countries including US, UK, The Netherlands, Germany, India and China. .
Research Partnership opens new office in Lyon, France

She will have a remit to grow and expand the Lyon office as well as to service existing clients based in France, Switzerland and Germany.
Speakers Announced: Maintaining Market Access Continuity through a Global Pandemic Webinar

Dr. Mathias Flume, Head of Prescription Management at KVWL, Germany. Professor Fabrizio Gianfrate, Professor of Health Economics at Rome and Ferrara Universities.
HARNESSING TECHNOLOGY TO TRANSFORM HEALTHCARE IN THE DIGITAL AGE

5G:The data transmission speed and low latency of 5G holds the potential to wirelessly transfer a doctors’ physical skills to another remote location; a doctor in Germany could guide a
Pricing and Market Access Simulator

Germany, Italy, Netherlands, Poland, Portugal, Scotland, Spain, Sweden, and US.